WednesdayAug 03, 2022 2:34 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now named CYB004-E, was acquired from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) FSE: 1XU1) through Cybin IRL Limited, Cybin’s wholly owned subsidiary… The adaptive, randomized, double-blinded, placebo-controlled, single-ascending-dose study produced notable results. According to the…

Continue Reading

WednesdayAug 03, 2022 2:19 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Continues to Make Strides in Clean Tech Market

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) recently held its annual general meeting in which all seven of its board members were re-elected, with a new Chair, David Farrell. “Hillcrest also announced the completion of its transition toward clean energy technologies by formally announcing the end of its oilfield activities,” reads a recent article. “Hillcrest continues to make strides in its new clean tech market, where it concentrates on offering a flexible, single-inverter architecture applicable at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of electric vehicles to providing full-cycle efficiency and…

Continue Reading

WednesdayAug 03, 2022 2:00 pm

QualityStocksNewsBreaks – Why DPCM Capital Inc. (NYSE: XPOA) Is ‘One to Watch’

DPCM Capital (NYSE: XPOA), a special purpose acquisition company, is set to be part of a newly formed company, D-Wave Quantum Inc., following the expected closing of a transaction contained in a definitive agreement between itself and D-Wave Systems Inc., a leader in quantum computing systems, software and services. D-Wave is “focused on delivering customer value via practical applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection, and financial modeling,” a recent article reads. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization…

Continue Reading

WednesdayAug 03, 2022 1:51 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Announces Significant Expansion of Service to PG&E, Utility Company Doubles Number of ASRs under Contract

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to expand its footprint as new clients sign up for the K5 Autonomous Security Robots (“ASRs”) and existing clients add to their contracts. The most recently announced growth comes as the Pacific Gas and Electric Company (“PG&E”), the leading subsidiary of the holding company PG&E Corporation (NYSE: PCG), has ordered an additional five ASRs. PG&E has now contracted with Knightscope for 10 robots, which provide the levels of safety and overwatch necessary to secure the client’s properties. According to the announcement, PG&E first…

Continue Reading

WednesdayAug 03, 2022 1:30 pm

QualityStocksNewsBreaks – Iconic Brands Inc. (ICNB) Achieves Record Revenues in Q1 2022

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and non-alcohol beverages, today released its financial results for the first quarter ended March 31, 2022. Among the highlights, the company reported $4,046,797 in total revenue for the first quarter, representing an increase of 538%, as well as $1,841,758 in gross profit, an increase of approximately 483% year over year. “The first quarter of 2022 was a testament to the strength of our business. We had record revenue for FY 2021 at $4.9 million, and this year we were able to achieve nearly that in just…

Continue Reading

WednesdayAug 03, 2022 10:26 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Adds EV Technology Team Centrally Located to Motor City Resources

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the addition of a new EV Technology team, focusing on developing EV technologies for Mullen’s portfolio of commercial vans. Located in Pontiac, Michigan, and centrally located to all automotive resources the Motor City Area has to offer, the team will be home to a new division of engineers and technology developers focused on Mullen’s Class 1 – 5 commercial vehicle development. The “Detroit Tech Center” and its team will play a critical role in Mullen’s goal of developing highly efficient EV technology that utilizes less energy consumption while…

Continue Reading

TuesdayAug 02, 2022 3:12 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) Announces Record Results for Q2 2022

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0), a publicly-traded investment company, today announced its second quarter 2022 financial results, including record revenue, gross profit and net earnings of its wholly-owned portfolio company Belle Pulses Ltd. “Belle Pulses’ performance is exceeding expectations, and we remain very pleased with the growth rate and strong ability to execute from Tony and Francis Gaudet as they continue to lead Belle Pulses. The team delivered record revenue and record gross profit as they fulfill their mission to feed families globally, while our CPG investments continue to scale rapidly across channels. I am…

Continue Reading

TuesdayAug 02, 2022 1:50 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Helping Innovators of Today, Leaders of Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. Studies have also demonstrated DehydraTECH’s ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances, with cannabinoids by as much as 27x compared to standard industry formulations, a benefit that opens significant possibilities for important drug delivery. “DehydraTECH’s application in the cannabis sector is seeing a boom, particularly with the recent expansion of Boldt Runners Corporation, a…

Continue Reading

TuesdayAug 02, 2022 12:39 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO Spotlighted in Benzinga Live Interview

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, will be the topic of discussion in an upcoming Benzinga YouTube channel interview. The live interview, hosted by Zunaid Sulemanet and slated for Aug. 4, 2022, at 1:30 p.m. ET will feature Mullen CEO and chair David Michery. According to the announcement, Michery’s previous interviews with Benzinga have been some of its most popular events, with viewers from around the world watching the live one-on-one discussions. “I look forward to connecting with Benzinga later this week, especially after a recent health event that kept me away from the office for…

Continue Reading

TuesdayAug 02, 2022 12:19 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast

Aditxt (NASDAQ: ADTX) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Amro Albanna, co-founder, chairman and CEO of Aditxt, joined the latest episode to provide an overview of the company and discuss its business model. “We are a biotech innovation company, and our focus is on immune diseases. The reality is that immune diseases are caused either by someone having too little immune response or too much immune response,” Albanna said. “When you have too little immune response and you’re dealing with COVID-19, we all understand…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered